1. HBW Insight
  2. >>Health
  3. >>Policy & Regulation

US FDA Asks For Comments On Reauthorizing OMUFA, A Program Still New To OTC Industry

 
• By Malcolm Spicer

Agency conducting all-day online meeting on 28 September to discuss proposed first reauthorization of OMUFA program established with its first five-year authorization in 2020 in legislation to overhaul the OTC monograph program.

• Source: Shutterstock

An upcoming US Food and Drug Administration workshop is on an OTC program established four years ago but might seem like it started only yesterday, its Over-the-Counter Monograph Drug User Fee program.

The agency is conducting an all-day public meeting online on 28 September from its White Oak headquarters campus in Silver...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Regulation

More from Policy & Regulation